Old Web
English
Sign In
Acemap
>
Paper
>
Clinical Study Results of Baricitinib (JAK1/2 Inhibitor): - A New Oral Treatment for Atopic Dermatitis -
Clinical Study Results of Baricitinib (JAK1/2 Inhibitor): - A New Oral Treatment for Atopic Dermatitis -
2021
Michihiro Hide
Yuichiro Tsunemi
Yoshitaka Isaka
Atsushi Nishikawa
Hitoe Torisu-Itakura
Kenji Kabashima
Keywords:
oral treatment
Dermatology
clinical study
Baricitinib
Medicine
Atopic dermatitis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
26
References
0
Citations
NaN
KQI
[]